Veron P. Browne

Member Board of Trustees @Oratory Prep

Clifton, NJ, US
EMAILS
v••••••@eagleus.com
MOBILE NUMBERS
+19•••••••95

Signup · Get unlimited contacts

WORK HISTORY

Jan 2023 — Present

Member Board of Trustees @Oratory Prep

View department →

Summit, NJ, US

Provide strategic, financial, and governance oversight to ensure the long-term growth and sustainability of Oratory Prep.• Guide strategic planning and capital investments aligned with institutional growth and community impact.• Review financial performance and operational risk, ensuring transparency and sustainability.• Support executive leadership evaluation, policy development, and compliance to strengthen governance and mission delivery.

EDUCATION

N/A

Oratory Prep

High School Diploma, Biology and Chemistry

N/A

Franklin Pierce University

B.S, Biology and Chemistry

N/A

University of the Sciences in Philadelphia

PhD, Pharmacology and Toxicology

N/A

LIU Brooklyn

M.S., Industrial Pharmacy

SKILLS

Sds-PageFormulationStudy MonitoringCellIn VivoMicroscopyLaboratoryDrug DevelopmentWestern BlottingPcrPharmacokineticsTransfectionGlpPharmacologyCell CultureCell BiologyDmpkHplcTissue CulturePurificationProtein ExpressionIn VitroAnimal DevelopmentData AnalysisR&DChemistryUv/VisAssay DevelopmentElisaPharmaceutical IndustrySopFdaDrug DeliveryProject ManagementGel ElectrophoresisToxicologyQpcrMolecular BiologyMetabolic SyndromesLc-Ms

ABOUT VERON P. BROWNE

PhD-trained toxicologist, pharmacologist and executive leader with 20+ years of experience driving drug development strategy across preclinical, clinical, and regulatory domains. I specialize in translating complex science into business value — helping biotech and pharma organizations de-risk assets, accelerate development, and position programs for partnership, licensing, or acquisition.Throughout my career, I’ve led IND-enabling programs, PMR strategies, and translational initiatives spanning oncology, neuroscience, rare, and critical care indications. I integrate scientific rigor with commercial and regulatory foresight to guide high-stakes decisions — from early discovery through clinical proof-of-concept and portfolio optimization.At the intersection of Corporate and Clinical Development, my work focuses on:Asset evaluation, due diligence, and portfolio strategyIND-to-market development planning and regulatory alignmentTranslational and clinical study design that supports M&A and investor goalsCross-functional leadership bridging R&D, medical, and business strategyI’m passionate about connecting science with strategy — enabling organizations to make smarter investments, deliver transformative therapies, and maximize both patient and enterprise impact.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.